Table 6 Characteristics of the patients included in the meta-analysis
From: A meta-analysis of the efficacy of fibromyalgia treatment according to level of care
Total | % | Control group | % | Intervention group | % | |
|---|---|---|---|---|---|---|
Level of care | ||||||
Primary care | 4505 | 57.8 | 2127 | 57.6 | 2378 | 58.1 |
Specialised care | 3284 | 42.2 | 1567 | 42.4 | 1717 | 41.9 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Kind of treatment | ||||||
Pharmacological | 5706 | 73.3 | 2684 | 72.7 | 3022 | 73.8 |
Non-pharmacological | 2083 | 26.7 | 1010 | 27.3 | 1073 | 26.2 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Outcome assessed | ||||||
Anxiety/depression | 1195 | 15.3 | 570 | 15.4 | 625 | 15.3 |
Quality of life | 115 | 1.5 | 51 | 1.4 | 64 | 1.6 |
Pain | 2074 | 26.6 | 980 | 26.5 | 1094 | 26.7 |
Fatigue | 650 | 8.3 | 320 | 8.7 | 330 | 8.1 |
Tender points | 1533 | 19.7 | 738 | 20.0 | 795 | 19.4 |
Insomnia | 397 | 5.1 | 196 | 5.3 | 201 | 4.9 |
Global function | 1825 | 23.4 | 839 | 22.7 | 986 | 24.1 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Methodological quality | ||||||
1 to 2 | 595 | 7.6 | 289 | 7.8 | 306 | 7.5 |
3 to 4 | 3396 | 43.6 | 1577 | 42.7 | 1819 | 44.4 |
5 to 6 | 3798 | 48.8 | 1828 | 49.5 | 1970 | 48.1 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Length of treatment (weeks) | ||||||
0 to 8 | 3644 | 46.8 | 1750 | 47.4 | 1894 | 46.3 |
09 to 16 | 3467 | 44.5 | 1678 | 45.4 | 1789 | 43.7 |
17 to 24 | 678 | 8.7 | 266 | 7.2 | 412 | 10.1 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Age | ||||||
30 to 39 | 253 | 3.2 | 125 | 3.4 | 128 | 3.1 |
40 to 49 | 6662 | 85.5 | 3140 | 85.0 | 3522 | 86.0 |
50 to 59 | 874 | 11.2 | 429 | 11.6 | 445 | 10.9 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Percentage of women | ||||||
< 80 | 151 | 1.9 | 73 | 2.0 | 78 | 1.9 |
80 to 89 | 2258 | 29.0 | 1111 | 30.1 | 1147 | 28.0 |
90 to 99 | 2874 | 36.9 | 1297 | 35.1 | 1577 | 38.5 |
100 | 2506 | 32.2 | 1213 | 32.8 | 1293 | 31.6 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Duration of the disorder (years) | ||||||
0 to 5 | 1459 | 25.3 | 710 | 26.3 | 749 | 24.5 |
6 to 10 | 2987 | 51.9 | 1344 | 49.7 | 1643 | 53.8 |
11 to 15 | 1310 | 22.8 | 649 | 24.0 | 661 | 21.7 |
Overall | 5756 | 100.0 | 2703 | 100.0 | 3053 | 100.0 |
Country | ||||||
Germany | 410 | 5.3 | 206 | 5.6 | 204 | 5.0 |
Belgium | 459 | 5.9 | 216 | 5.8 | 243 | 5.9 |
Brasil | 278 | 3.6 | 132 | 3.6 | 146 | 3.6 |
Canada | 1655 | 21.2 | 737 | 20.0 | 918 | 22.4 |
Finland | 488 | 6.3 | 240 | 6.5 | 248 | 6.1 |
Holland | 174 | 2.2 | 86 | 2.3 | 88 | 2.1 |
Norway | 195 | 2.5 | 102 | 2.8 | 93 | 2.3 |
Sweden | 254 | 3.3 | 126 | 3.4 | 128 | 3.1 |
Switzerland | 276 | 3.5 | 135 | 3.7 | 141 | 3.4 |
Turkey | 298 | 3.8 | 148 | 4.0 | 150 | 3.7 |
USA | 3302 | 42.4 | 1566 | 42.4 | 1736 | 42.4 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |
Year of publication | ||||||
1994 | 620 | 8.0 | 234 | 6.3 | 386 | 9.4 |
1995 | 178 | 2.3 | 86 | 2.3 | 92 | 2,.2 |
1996 | 1306 | 16.8 | 637 | 17.2 | 669 | 16.3 |
1997 | 38 | 0.5 | 18 | 0.5 | 20 | 0.5 |
1998 | 724 | 9.3 | 349 | 9.4 | 375 | 9.2 |
2000 | 207 | 2.7 | 102 | 2.8 | 105 | 2.6 |
2001 | 926 | 11.9 | 460 | 12.5 | 466 | 11.4 |
2002 | 780 | 10.0 | 372 | 10.1 | 408 | 10.0 |
2003 | 392 | 5.0 | 196 | 5.3 | 196 | 4.8 |
2004 | 1241 | 15.9 | 621 | 16.8 | 620 | 15.1 |
2005 | 1377 | 17.7 | 619 | 16.8 | 758 | 18.5 |
Overall | 7789 | 100.0 | 3694 | 100.0 | 4095 | 100.0 |